TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma

Cholangiocarcinoma is a relatively uncommon but highly lethal malignancy. Improving outcomes in patients depends on earlier diagnosis and appropriate treatment; however, no satisfactory diagnostic biomarkers or targeted therapies are currently available. To address this shortcoming, we analyzed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Cheng-Han, Chu, Cheng-Ying, Lin, Sey-En, Yang, Yu-Chen S.H., Chang, Hung-Shu, Yen, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281536/
https://www.ncbi.nlm.nih.gov/pubmed/32365487
http://dx.doi.org/10.3390/cancers12051105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281536/
https://www.ncbi.nlm.nih.gov/pubmed/32365487
http://dx.doi.org/10.3390/cancers12051105

Ejemplares similares